PDF ChineseInvestors.com Inc. Sector: Media / Internet Industry ...

[Pages:2] Inc.

Ticker: (OTCQB: CIIX)

Page 1 of 2

Corporate Profile

as of May 31, 2019

Sector: Media / Internet Industry: Communication

Services/Retail Website:

Background and History

, Inc. ("CIIX" or "the Company"), founded in 1999, is headquartered in San Gabriel, California, with offices in New York City, Richmond (Vancouver) BC, and Shanghai, China. The Company focuses on media services geared toward trading and investing in stocks and currencies and investor relations services. In addition to its core business, in 2017 the Company diversified by establishing two separate consumer product subsidiaries in the US and China, focusing on hemp oil and hemp health care products. With the recent passage of the Farm Bill, the sale of Hemp Products (without TCH) is now federally legal within the US and legal within all 50 States. The retail market for CBD products is currently $1 Billion dollars in the United States.

Key Statistics

Price 5/31/2019 52 Week High 52 Week Low Avg. Vol (30day) Market Cap (Interday)M Price/Sales (TTM) Common Shares Outstanding (M)

0.44 1.25 0.37 59,754 19.06 5.52 43.33

The Company's primary product offering, within its core financial media communications business, is the creation of real-time stock market commentary, analysis, and educational services in the Chinese language (). Content offered includes information about U.S. publicly-traded stocks, foreign currencies, and now digital currencies, with free quotes, charts, market news, and links to investment research. CIIX also offers paid premium subscription services that include access to sample investment portfolios (for educational purposes), as well as real-time trading demonstrations.

Hemp Subsidiaries Drive Revenue Growth

In early 2017, after taking notice of the unprecedented opportunities in the legal industrial hemp industry, CIIX registered XiBiDi Biotechnology Co., Ltd. ("CBD Biotechnology Co., Ltd"), a wholly-owned Chinese subsidiary offering non-industrial hemp products direct to consumers. The Company offers its hemp products online as well as via retail channels including its own flagship retail store. The Company has launched its "CBD Magic Hemp Series" skin care line. In July 2017, CBD Biotechnology Co. Ltd., officially filed a record of its first line of non-industrial hemp-infused skin care products with the China Food and Drug Administration (CFDA). Although there has been published literature by the CFDA indicating that Cannabis can legally be added to skin care products, many Chinese skin care manufacturers have not yet entered this market. The company recently announced a pending IPO of CBD Biotech which when completed will allow to return to its original platform of developing proprietary financial news media and content. The IPO includes the appointment of CFO Alex Hamilton, whose primary focus is on providing CBD-related products to China's mainland population and other Asian markets. The IPO is making progress, as it now has legal counsel and a broker dealer, and auditor. CBD Biotech is close to forming a board of directors and filing a registration statement.

Conv. Preferred Shares Outstanding (M)

7.74

Float(M)

39.06

EPS(TTM)

-0.30

Beta (3Y Monthly)

1.31

Source: Yahoo Finance / OTC Markets

Recent 2019 Highlights ? May 16, 2019, the Company an-

nounced CBD Biotechnology Co. Ltd., recently exhibited its selfbranded, hemp-infused skin care line at the 29th Vietnam Expo in Hanoi. The Vietnam Expo is an important business destination for trade promotion, foreign relations and commerce between Vietnamese and foreign enterprises.

? April 17, 2019, the Company reported an 81 percent increase in total revenue for Q3FY2019 of $1,444,822, up from $796,304, as well as a 579 percent increase in hemp and CBD sales revenues and 6 percent increase in subscription revenues, all up from the same quarter in the prior year.

In April 2017, the Company established , Inc., a wholly-owned U.S. subsidiary. , Inc. is responsible for the development and operation of online and retail sales of non-industrial hemp-based health products in the United States via its website . The US subsidiary operates a retail store deemed the "Chinese Wellness Center," in the predominantly Chinese community of San Gabriel, California, and plans to open a pop-up keyosk in the Glendale Mall in Los Angeles County. The subsidiary's first CBD oil product line, "OptHempTM", a premium pri-

CIIX's Chinese Subsidiary Plans an IPO Spin Off Later This Year

? March 4, 2019, the Company announced the appointment of Patrick Leung as its new CFO. Leung comes from Kirin Group Holdings Limited, where he served as the executive director and company secretary. Leung has more than two decades of experience in the public sector, serving in various executive and directorial roles at a number of companies listed on the Stock Exchange of Hong Kong and Nasdaq.

vate label oil, is manufactured in Colorado using a CO2 Extraction process and has fast become its best seller. "OptHemp" oil sits alongside the Company's other hemp-based products, such as premium hemp gummies, water soluble soft gels, and ointments. These hemp segment subsidiaries have been a major driver of growth for the Company.

New Products Include Vitamin Sprays and CBD Combinations

? February 19, 2019, The Company announced that its subsidiary has completed a re branding of its consumer product line. The new brand will be offered under the name Opt Hemp and Opt2Mist Hemp CBD lines.

The information presented herein is not to be construed as an offer to sell, nor a solicitation of an offer to purchase, any securities. This corporate profile is not a research report, but a com-

pilation of information available to the public, which has been furnished by the featured company or gathered from other sources, in each case without independent verification, and no

representations are made as to he accuracy or validity thereof. The information may include certain forward-looking statements within the meaning of Section 21E of the SEC Act of 1934,

which may be affected by unforeseen circumstances or certain risks. Any investment in securities contains inherent risks and should only be done after consulting an investment professional.

The featured company will pay a fee of $4500 in cash to Alan Stone & Company LLC for preparation and distribution of this updated profile, including other potential fees associated with

various consulting and investor relation services. For complete disclaimer information, the readers are hereby referred to the Disclaimer Page at the website.

Copyright ? May 2019 Alan Stone & Company LLC and WallStreet ResearchTM, All Rights Reserved



 Inc.

Ticker: (OTCQB: CIIX)

Page 2 of 2

New Developments / New Products

Corporate Profile

as of May 31, 2019

Sector: Media / Internet Industry: Communication

Services/Retail Website:

CBD Biotechnology Co. Ltd. launched, in Q2, its CBD Hemp Wine private brand, hemp-infused rice wine product line. Management believes there are tremendous long-term potential benefits of hemp and rice wine, and rapid revenue growth is anticipated. On December 4, 2018, the Company announced an agreement with BCDBG, Inc. to exclusively market in Asian markets the complete Vitamist product line. The licensing agreement includes both domestic and international markets and will feature numerous proprietary vitamin formulas. The Company is currently utilizing the spray technology delivery system for CBD consumption. Under the agreement, BCDBG has developed exclusive and proprietary products for the Company, including vitamin sprays and vitamins/CBD spray combinations.

CIIX has created Chinese Wellness Center (CWC), as a wholly-owned subsidiary of , Inc. CWC is specializing in the promotion and sales of high-end nutritional supplements and CBD hemp oil in the United States. The head office is located in San Gabriel , CA and has branches in various cities of North America. CWC currently has 250 dealerships in Los Angeles and is the only company in the Chinese community to promote and sell hemp products. With the main focus being to find new and innovative ways to help the Chinese community stay healthy, CWC has launched NuLeaf Natural as well as its own CBD Products. The Company is now re branding the OPT hemp lines to include, Opt Hemp topical cosmetics, OPT2Mist, a nutritional spray line, and NuLeaf Naturals, a high-quality and organic hemp oil product line sourced from Colorado. These new products have the potential to become large growth opportunities for the firm.

Financial Results

During the nine month period ended Feb. 28, 2019, the Company reported $2,817,756 in total revenue, up 67.8 percent from $1,679256 in the comparable nine months last year. The Company reported total annual revenues for the year ended May 31, 2018 of $2.35 million, up 41 percent from the previous year of $1.67 million. This increase was primarily attributable to increased product sales of its new retail and online product line "OptHemp" in the US; and a variety of Hemp infused products in China. The Company has increased revenue from its various consulting and investor relations services. The Company reported a net loss of $7.4 million for the year ended May 31, 2018 vs. $3.3 million net loss in the previous year. Loss per share improved to ($.58) from ($.86). The net loss for the nine months ended 2/28/19 was $6.7 Million or -22 cents per share.

The Company announced it engaged Bousted Securities, LLC to manage an IPO for its CBD Biotechnology Co. Ltd. subsidiary, planned to come to market during the fall of 2019. The Company raised $8.45 million dollars in the last nine months through the issuance of Series D Preferred Stock and the sale of Notes. The Company improved its balance sheet by growing total assets to $4.99 million as of February 28, 2019, and converted a substantial number of preferred shares (multiple series) into common stock, thereby increasing its common share count to 43.33 million.

Corporate Contact Information

Inc.

Warren Wang, CEO Alan Klitenic, Investor Relations (214) 636-2548 227 W. Valley Blvd. Suite 208 A San Gabriel, CA 91776 Email: warrenwang@ Headquarters: (888) 789-1670



Figure 1: CIIX 1 Year Price Chart

Figure 2: CIIX 2 Month Price Chart

The Company's New CBD infused Wine

All figures beloww are quoted in US Dollars and in Thousands

Income Statement FY 5/31/17 FY 5/31/18 9 Mo 2/28/19 Balance Sheet

Revenue

$ 1,668

2,353

2,818 Cash

Operating Loss $ (4,915) (7,215)

(8,075) Total Assets

Net Loss

$ (3,337) (7,406)

(6,670) Total Liabilities

Loss Per Share

$ (0.86)

(0.58)

(0.22) Total Shareholder's Equity

FY 5/31/17

$ 1,771 $ 3,172 $ 1,781 $ 1,391

FY 5/31/18 1,390 3,676 2,751 926

as of 2/28/19 Cash Flow Statement FY 5/31/17 FY 5/31/18 9 Mo 2/28/19

2,288 Operating Cash Flow (4,589) (7,349)

(8,398)

4,992 Investing Cash Flow

1,412

(94)

2,249

5,937 Financing Cash Flow

4,750

7,072

7,060

(945) Cash at end of period 1,771

1,390

2,288

The information presented herein is not to be construed as an offer to sell, nor a solicitation of an offer to purchase, any securities. This corporate profile is not a research report, but a compilation of information available to the public, which has been furnished by the featured company or gathered from other sources, in each case without independent verification, and no representations are made as to he accuracy or validity thereof. The information may include certain forward-looking statements within the meaning of Section 21E of the SEC Act of 1934, which may be affected by unforeseen circumstances or certain risks. Any investment in securities contains inherent risks and should only be done after consulting an investment professional. The featured company will pay a fee of $4500 in cash to Alan Stone & Company LLC for preparation and distribution of this updated profile, including other potential fees associated with various consulting and investor relation services. For complete disclaimer information, the readers are hereby referred to the Disclaimer Page at the website.

Copyright ? May 2019 Alan Stone & Company LLC and WallStreet ResearchTM, All Rights Reserved



 ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download